FOXM1 and acute myeloid leukemia: We previously showed that knock-down of FOXM1, or TMPP treatment, markedly decreased the protein expression of the mitotic regulators Skp2, Cdc25B, Cyclin B1, Survivin, KIS, Aurora-B kinase in AML cells [1], [2].